Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 29,184 | 20,862 | 13,900 | 16,983 | 16,943 |
| Operating Income | -29,184 | -20,862 | -13,900 | -16,983 | -16,943 |
| Interest Expense | 77 | 76 | 0 | 0 | 0 |
| Other Income | 131 | -3,877 | 8,997 | 498 | -14 |
| Pre-tax Income | -29,130 | -24,815 | -4,903 | -16,485 | -16,957 |
| Net Income Continuous | -29,130 | -24,815 | -4,903 | -16,485 | -16,957 |
| Net Income | $-29,130 | $-24,815 | $-4,903 | $-16,485 | $-16,957 |
| EPS Basic Total Ops | -0.76 | -0.65 | -0.02 | -0.56 | -0.60 |
| EPS Basic Continuous Ops | -0.76 | -0.65 | -0.02 | -0.56 | -0.60 |
| EPS Diluted Total Ops | -0.76 | -0.65 | -0.02 | -0.56 | -0.60 |
| EPS Diluted Continuous Ops | -0.76 | -0.65 | -0.02 | -0.56 | -0.60 |
| EBITDA(a) | $-28,394 | $-20,071 | $-13,110 | $-16,193 | $-16,123 |